| Literature DB >> 27031291 |
Jian-Zhang Li1, Zhen-Long Wang2, Wan-Hai Xu1, Qing Li1, Lin Gao1, Zi-Ming Wang2.
Abstract
Abnormal microRNA (miR) expressions were implicated in prostate cancer progression. We identified a novel miR-495, which was downregulated in prostate cancer, but not normal prostate cell lines. MiR-495 directly targeted the 3'-UTR of Akt and mTOR mRNAs. Expression of miR-495 in prostate cancer cells significantly downregulated Akt and mTOR, which further inhibited cancer cell proliferation, migration, and invasion in vitro. Function of miR-495 in vivo was examined in mouse xenograft model and was found to significantly inhibit the growth of tumors, mediated by repressing Akt and mTOR. Our report supported miR-495 as a novel tumor suppressor microRNA in prostate cancer.Entities:
Keywords: Akt; Mammalian target of rapamycin (mTOR); MicroRNA-495; Prostate cancer; Tumorigenesis
Mesh:
Substances:
Year: 2016 PMID: 27031291 DOI: 10.3109/07357907.2016.1156690
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176